Terns Pharmaceuticals Inc (TERN) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Terns Pharmaceuticals Inc   (NASDAQ: TERN)


Terns Pharmaceuticals Inc 's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Terns Pharmaceuticals Inc 's ROA in the fourth quarter of 2025?
Terns Pharmaceuticals Inc recorded a cumulative net loss of $-96 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -19.38%.

However, within the Healthcare sector 416 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from 3727 to 4037.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Total Assets Change 182.13 % -20.33 % 38.78 % 37.5 % 35.31 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -96 -94 -92 -90 -89
Return On Assets (TTM) -19.38 % -28.52 % -26.19 % -27.56 % -29.15 %
TERN's Total Ranking # 4037 # 3727 # 3703 # 3796 # 4438
Total Assets (TTM) in million 1,025 301 320 339 363
Seq. Total Assets Change 240.16 % -5.95 % -5.57 % -6.61 % -3.94 %
Seq. Net Income Change - - - - -

TERN's 5 Years Annual ROA >> Back to TERN Management Effectiveness >> Compare TERN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 159
Sector # 417
Overall # 4001

Return On Assets Statistics
High Average Low
-19.37 %
-29.85 %
-37.69 %
(Dec 31 2025)   (Jun 30 2024)





Financial Statements
Terns Pharmaceuticals Inc 's Assets $ 1,025 million TERN's Balance sheet
Terns Pharmaceuticals Inc 's Income $ -24 million Quarterly TERN's Income Statement
TERN's Income by Division See TERN's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 182.13 % 35.31 % -6.45 % 70.78 % -
Total Assets in million 1,025 363 269 287 168
Y / Y Net Income Change - - - - -
Net Income in million -96 -89 -90 -60 -50
Annual Return On Assets -9.39 % -24.46 % -33.6 % -21.02 % -29.84 %

TERN's 5 Years Annual ROA >> Back to TERN Management Effectiveness >> Compare TERN ROA to its Competitors



More Return On Assets Ratios
TERN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TERN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TERN's Competitors
Subscribers only: Roa for Terns Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for TERN's Customers

You may also want to know
TERN's Roi TERN's Inventory Turnover Ratio TERN's Growth Rates TERN's Dividend Comparisons
TERN's Profitability Ratios TERN's Asset Turnover Ratio TERN's Dividend Growth
TERN's Roe TERN's Valuation Ratios TERN's Financial Strength Ratios TERN's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA

Date modified: 2026-06-22T14:32:46+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.